ID   IR983F
AC   CVCL_7675
SY   IR 983F; IR 983 F; 983
DR   CCRID; 1101RAT-PUMC000221
DR   Wikidata; Q54898238
RX   CelloPub=CLPUB00609;
RX   DOI=10.1016/B978-0-08-027988-6.50144-0;
RX   PubMed=6678801;
CC   Group: Hybridoma fusion partner cell line.
CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC   Misspelling: IRF938F; Note=Occasionally.
CC   Breed/subspecies: LOU/C.
DI   NCIt; C125416; Rat plasma cell myeloma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   72W
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 14
//
RX   CelloPub=CLPUB00609;
RA   Digneffe C., Cormont F., Platteau B., Bazin H.;
RT   "Fusion cell lines.";
RL   (In) Rat hybridomas and rat monoclonal antibodies; Bazin H. (eds.); pp.69-74; CRC Press; Boca Raton (1990).
//
RX   DOI=10.1016/B978-0-08-027988-6.50144-0;
RA   Bazin H.;
RT   "Production of rat monoclonal antibodies with the Lou rat non
RT   secreting IR983F myeloma cell line.";
RL   Prot. Biol. Fluids 29:615-618(1982).
//
RX   PubMed=6678801; DOI=10.1089/hyb.1983.2.355;
RA   Lebacq-Verheyden A.-M., Neirynck A., Ravoet A.-M., Bazin H.;
RT   "Rat hybridoma technology: culturing of rat myeloma cell line IR983F
RT   prior to cell fusion.";
RL   Hybridoma 2:355-358(1983).
//